Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
125.3 USD | -0.09% |
|
-1.57% | +14.93% |
03:32pm | TD Cowen Adjusts Price Target on Merck to $140 From $135 | MT |
Jul. 16 | Merck: to present its advances in HIV at AIDS 24 | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.93% | 318B | |
+57.09% | 848B | |
+31.64% | 627B | |
-0.82% | 363B | |
+12.19% | 299B | |
+15.36% | 243B | |
+16.77% | 225B | |
+15.51% | 179B | |
+3.59% | 167B | |
+2.43% | 125B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Transcript : Merck & Co., Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 04